Literature DB >> 17130482

Decreased hepatic futile cycling compensates for increased glucose disposal in the Pten heterodeficient mouse.

Jun Xu1, Lori Gowen, Christian Raphalides, Katrina K Hoyer, Jason G Weinger, Mathilde Renard, Joshua J Troke, Bhavapriya Vaitheesyaran, W N Paul Lee, Mohammed F Saad, Mark W Sleeman, Michael A Teitell, Irwin J Kurland.   

Abstract

Despite altered regulation of insulin signaling, Pten(+/-) heterodeficient standard diet-fed mice, approximately 4 months old, exhibit normal fasting glucose and insulin levels. We report here a stable isotope flux phenotyping study of this "silent" phenotype, in which tissue-specific insulin effects in whole-body Pten(+/-)-deficient mice were dissected in vivo. Flux phenotyping showed gain of function in Pten(+/-) mice, seen as increased peripheral glucose disposal, and compensation by a metabolic feedback mechanism that 1) decreases hepatic glucose recycling via suppression of glucokinase expression in the basal state to preserve hepatic glucose production and 2) increases hepatic responsiveness in the fasted-to-fed transition. In Pten(+/-) mice, hepatic gene expression of glucokinase was 10-fold less than wild-type (Pten(+/+)) mice in the fasted state and reached Pten(+/+) values in the fed state. Glucose-6-phosphatase expression was the same for Pten(+/-) and Pten(+/+) mice in the fasted state, and its expression for Pten(+/-) was 25% of Pten(+/+) in the fed state. This study demonstrates how intra- and interorgan flux compensations can preserve glucose homeostasis (despite a specific gene defect that accelerates glucose disposal) and how flux phenotyping can dissect these tissue-specific flux compensations in mice presenting with a "silent" phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17130482     DOI: 10.2337/db06-0002

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Advantages of dynamic "closed loop" stable isotope flux phenotyping over static "open loop" clamps in detecting silent genetic and dietary phenotypes.

Authors:  Bhavapriya Vaitheesvaran; Fu-Yu Chueh; Jun Xu; Chuck Trujillo; M F Saad; W N P Lee; Owen P McGuinness; Irwin J Kurland
Journal:  Metabolomics       Date:  2009-11-12       Impact factor: 4.290

2.  Adipose-specific ablation of Nrf2 transiently delayed high-fat diet-induced obesity by altering glucose, lipid and energy metabolism of male mice.

Authors:  Le Zhang; Kalavathi Dasuri; Sun-Ok Fernandez-Kim; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

3.  MKR mice have increased dynamic glucose disposal despite metabolic inflexibility, and hepatic and peripheral insulin insensitivity.

Authors:  B Vaitheesvaran; D LeRoith; I J Kurland
Journal:  Diabetologia       Date:  2010-06-25       Impact factor: 10.122

4.  Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver.

Authors:  Shawn C Burgess; TianTeng He; Zheng Yan; Jill Lindner; A Dean Sherry; Craig R Malloy; Jeffrey D Browning; Mark A Magnuson
Journal:  Cell Metab       Date:  2007-04       Impact factor: 27.287

5.  Peripheral effects of FAAH deficiency on fuel and energy homeostasis: role of dysregulated lysine acetylation.

Authors:  Bhavapriya Vaitheesvaran; Li Yang; Kirsten Hartil; Sherrye Glaser; Stephen Yazulla; James E Bruce; Irwin J Kurland
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

6.  Enhanced energy expenditure, glucose utilization, and insulin sensitivity in VAMP8 null mice.

Authors:  Haihong Zong; Cheng-Chun Wang; Bhavapriya Vaitheesvaran; Irwin J Kurland; Wanjin Hong; Jeffrey E Pessin
Journal:  Diabetes       Date:  2010-09-28       Impact factor: 9.461

7.  Application of combined omics platforms to accelerate biomedical discovery in diabesity.

Authors:  Irwin J Kurland; Domenico Accili; Charles Burant; Steven M Fischer; Barbara B Kahn; Christopher B Newgard; Suma Ramagiri; Gabriele V Ronnett; John A Ryals; Mark Sanders; Joe Shambaugh; John Shockcor; Steven S Gross
Journal:  Ann N Y Acad Sci       Date:  2013-05-09       Impact factor: 5.691

8.  Alteration of de novo glucose production contributes to fasting hypoglycaemia in Fyn deficient mice.

Authors:  Yingjuan Yang; Elena Tarabra; Gong-She Yang; Bhavapriya Vaitheesvaran; Gustavo Palacios; Irwin J Kurland; Jeffrey E Pessin; Claire C Bastie
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

9.  Hepatic MiR-291b-3p Mediated Glucose Metabolism by Directly Targeting p65 to Upregulate PTEN Expression.

Authors:  Jun Guo; Lin Dou; Xiangyu Meng; Zhenzhen Chen; Weili Yang; Weiwei Fang; Chunxiao Yang; Xiuqing Huang; Weiqing Tang; Jichun Yang; Jian Li
Journal:  Sci Rep       Date:  2017-01-05       Impact factor: 4.379

10.  Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.

Authors:  Rebecca A Haeusler; Kirsten Hartil; Bhavapriya Vaitheesvaran; Isabel Arrieta-Cruz; Colette M Knight; Joshua R Cook; Helene L Kammoun; Mark A Febbraio; Roger Gutierrez-Juarez; Irwin J Kurland; Domenico Accili
Journal:  Nat Commun       Date:  2014-10-13       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.